Adage Capital Partners
HOWL icon

Adage Capital Partners’s Werewolf Therapeutics HOWL Stock Holding History

Adage Capital Partners’s Portfolio HOWL Stock Details HOWL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,000,594
Closed -$4.24M – 914
2024
Q3 		$4.24M Hold
2,000,594
– – 0.01% 731
2024
Q2 		$4.88M Sell
2,000,594
-1,000,000
-33% -$4.8M 0.01% 716
2024
Q1 		$19.4M Sell
3,000,594
-33,661
-1% -$196K 0.04% 460
2023
Q4 		$11.7M Buy
3,034,255
+2,033,658
+203% +$5.19M 0.02% 566
2023
Q3 		$2.14M Hold
1,000,597
– – ﹤0.01% 735
2023
Q2 		$3.05M Hold
1,000,597
– – 0.01% 715
2023
Q1 		$2.6M Hold
1,000,597
– – 0.01% 750
2022
Q4 		$2.05M Hold
1,000,597
– – ﹤0.01% 816
2022
Q3 		$4.51M Hold
1,000,597
– – 0.01% 790
2022
Q2 		$4.09M Buy
1,000,597
+25,000
+3% +$114K 0.01% 822
2022
Q1 		$4.29M Buy
975,597
+15,149
+2% +$106K 0.01% 846
2021
Q4 		$11.4M Sell
960,448
-25,000
-3% -$377K 0.02% 660
2021
Q3 		$16.9M Sell
985,448
-15,149
-2% -$259K 0.03% 533
2021
Q2 		$17.4M Buy
+1,000,597
New +$13.7M 0.03% 520

Other funds holding HOWL

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Adage Capital Partners's HOWL Position: Q4 2024 in Review

Adage Capital Partners sold out of Werewolf Therapeutics (HOWL) in Q4 2024, closing a stake of 2,000,594 shares — an estimated $4.24M sold.

Adage Capital Partners first reported a position in HOWL in Q2 2021 and held it in 14 quarters. The position peaked at $19.4M in Q1 2024. 73 funds tracked by Wall St. Rank hold HOWL as of Q4 2024.

  • Adage Capital Partners reported no remaining Werewolf Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Adage Capital Partners sold 2,000,594 Werewolf Therapeutics shares in Q4 2024, an estimated $4.24M.
  • Adage Capital Partners first reported a position in Werewolf Therapeutics in Q2 2021 and held it in 14 quarters.
  • Adage Capital Partners's Werewolf Therapeutics position peaked at $19.4M in Q1 2024.
  • 73 funds tracked by Wall St. Rank held Werewolf Therapeutics as of Q4 2024.

Based on Adage Capital Partners's 13F filing for Q4 2024, filed 14 Feb 2025.